[Form 4] Doximity, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Doximity CFO Anna Bryson reported transactions on 08/26/2025. The filing shows the Reporting Person acquired 40,000 shares of Class A common stock through conversion/exercise and simultaneously sold 40,000 shares pursuant to a Rule 10b5-1 trading plan adopted on 05/27/2025. The sales were executed at a weighted-average price of $66.7561 per share, with sale prices ranging from $66.2250 to $67.2200. Following these transactions the Reporting Person beneficially owns 346,925 shares (direct). The filing also discloses outstanding stock option activity related to 40,000 options with an $8.26 exercise price.

Positive

• Sale executed under Rule 10b5-1 plan adopted 05/27/2025, indicating pre-planned transactions
• Reporting Person retains substantial ownership after transactions: 346,925 shares (direct)
• Full weighted-average sale price disclosed ($66.7561) with price range provided

Negative

• Insider reduced holdings by 40,000 shares, a ~10.3% decrease from 386,925 to 346,925 shares
• Material sale size (40,000 shares) could be perceived negatively by some investors despite being pre-planned

Insights

Financial Analyst

TL;DR: CFO executed pre-planned sales while retaining substantial stake; transactions appear routine, not an emergency liquidity event.

The Form 4 shows a contemporaneous acquisition/conversion of 40,000 shares and the sale of 40,000 shares under a Rule 10b5-1 plan adopted 05/27/2025, at a weighted-average price of $66.7561. Net holdings declined from 386,925 to 346,925, a reduction of ~10.3%. The presence of a 10b5-1 plan and the exercise/conversion activity supports a view that these are planned, administratively driven transactions rather than opportunistic insider sales.

Corporate Governance Expert

TL;DR: Transactions were executed under a documented 10b5-1 plan, meeting disclosure expectations for an officer.

The filing identifies Anna Bryson as CFO and indicates the sale occurred automatically pursuant to a 10b5-1 plan adopted on 05/27/2025, which provides the affirmative defense under Rule 10b5-1(c). The Form 4 properly reports conversion/exercise mechanics and resulting beneficial ownership of 346,925 shares. From a governance perspective, the disclosure is complete and consistent with routine insider trading policies.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bryson Anna

(Last) (First) (Middle)

DOXIMITY, INC.

500 THIRD STREET

(Street)

SAN FRANCISCO CA 94107

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Doximity, Inc. [ DOCS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/26/2025		C(1)		40,000	A	(1)	386,925	D
Class A Common Stock	08/26/2025		S(2)		40,000	D	$66.7561(3)	346,925	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.26	08/26/2025		M			40,000	(4)	02/04/2031	Class B Common Stock(5)	40,000	$0	247,268	D
Class B Common Stock	(5)	08/26/2025		M		40,000		(5)	(5)	Class A Common Stock	40,000	$0	40,000	D
Class B Common Stock	(5)	08/26/2025		C(1)			40,000	(5)	(5)	Class A Common Stock	40,000	$0	0	D

Explanation of Responses:

1. Each share of Class B Common Stock, par value $0.001 per share (the "Class B Common Stock"), converted into one share of Class A Common Stock, par value $0.001 per share (the "Class A Common Stock"), at the option of the holder.

2. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 27, 2025.

3. The price represents the weighted-average price of the shares sold in multiple transactions ranging from $66.2250 to $67.2200 per share, inclusive. The Reporting Person undertakes to provide the Issuer, a security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The stock option vests in 60 equal monthly installments after February 1, 2021, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The stock option was granted on February 5, 2021.

5. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder. Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock, upon the following: (1) the sale or transfer of such share of Class B Common Stock, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation; (2) the death or incapacity of the Reporting Person; and (3) on the final conversion date, defined as the earlier of (a) the tenth anniversary of the effectiveness of the registration statement in connection with the Issuer's initial public offering; or (b) the date specified by a vote of the holders of at least 66 2/3% of the outstanding shares of Class B Common Stock, voting as a single class.

Remarks:

	/s/ Jennifer Chaloemtiarana, Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Doximity CFO Anna Bryson report on Form 4 (DOCS)?

The Form 4 reports acquisition/conversion of 40,000 shares and the sale of 40,000 shares on 08/26/2025.

Were the sales by Anna Bryson part of a 10b5-1 trading plan?

Yes. The sales occurred automatically pursuant to a Rule 10b5-1 plan adopted on 05/27/2025.

At what price were the shares sold?

The filing discloses a weighted-average sale price of $66.7561, with individual sale prices ranging from $66.2250 to $67.2200.

How many shares does the Reporting Person own after these transactions?

After the reported transactions the Reporting Person beneficially owns 346,925 shares (direct).

Was there option activity reported for Anna Bryson?

Yes. The Form 4 lists activity related to 40,000 stock options with an exercise price of $8.26.